REP 3123 dihydrochloride(1013915-99-5)
- Name: REP 3123 dihydrochloride
- Synonyms:1013915-99-5;REP 3123 dihydrochloride;CRS3123 dihydrochloride;CRS-3123 dihydrochloride;IF2P0Y7Y0R;CRS3123 (dihydrochloride);(R)-(+)-5-[[3-[(6,8-Dibromochroman-4-yl)amino]propyl]amino]-4H-thieno[3,2-b]pyridin-7-one dihydrochloride;(R)-5-((3-((6,8-Dibromochroman-4-yl)amino)propyl)amino)thieno[3,2-b]pyridin-7(4H)-one dihydrochloride;Thieno(3,2-b)pyridin-7(4H)-one, 5-((3-(((4R)-6,8-dibromo-3,4-dihydro-2H-1-benzopyran-4-yl)amino)propyl)amino)-, hydrochloride (1:2);UNII-IF2P0Y7Y0R;SCHEMBL2172681;MS-30477;HY-115440;E98947;(R)-5-(3-(6,8-dibromochroman-4-ylamino)propylamino)thieno[3,2-b]pyridin-7(4H)-one dihydrochloride;5-[3-[[(4R)-6,8-Dibromo-3,4-dihydro-2H-chromen-4-yl]amino]propylamino]-4H-thieno[3,2-b]pyridin-7-one;dihydrochloride
- Molecular Formula:C19H21Br2Cl2N3O2S
- Molecular Weight:586.2
- CAS Registry Number:1013915-99-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1013915-99-5 REP 3123 dihydrochloride
Assay:99% Package:inquiry Transportation:inquiry Application:REP 3123 dihydrochloride is a selective inhibitor of methionyl-tRNA synthetase (MetRS) used as an antibiotic for the treatment of Clostridium difficile infection (CDI).
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 57694-21-0/10-Tert-butyl-13-methyl-2,5,8,11-tetraoxahexacyclo[7.4.0.01,3.04,6.07,9.010,12]tridecane
- 1638761-19-9/6-Methoxy-2-azaspiro[3.3]heptane hydrochloride
- 1774896-27-3/3-Bromo-2-(pyrrolidin-1-yl)benzaldehyde
- 412938-26-2/2-[(4,5-Dimethyl-furan-2-carbonyl)-amino]-benzoic acid
- 1245644-19-2/Tert-butyl 2-(2-nitroethyl)pyrrolidine-1-carboxylate
- 885513-46-2/Zinc bis-(methyl palmitoyl aspartate)
- 240115-91-7/4-[4-(2-pyridinyl)-1H-pyrazol-3-yl]morpholine
- 13896-88-3/1-Methyl[1,3]thiazolo[3,2-a]quinolin-10-ium perchlorate
- 1186404-82-9/4'-Chloro-3'-fluoro[1,1'-biphenyl]-4-carbohydrazide
- 1105045-66-6/Fmoc-D-phe(3-Br)-OH
- 1184920-25-9/6-(Pyrrolidin-1-yl)imidazo[1,2-b]pyridazine-2-carbaldehyde
- 1229623-68-0/3-[1-(2-Methoxy-phenyl)-5-oxo-pyrrolidin-3-yl]-3-oxo-propionic acid methyl ester
- 41174-78-1/1-(10-Acetyl-1,8-dimethyl-11-oxatricyclo[6.2.1.02,7]undeca-2,4,6,9-tetraen-9-yl)ethanone
- 444287-44-9/N-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)methyl)cyclopropanecarboxamide
- 934481-60-4/CC-11006
- 929116-08-5/Pinocarvyl isobutyrate
- 36103-48-7/1,2-Bis(trifluoromethyl)spiro[cyclopropene-3,9'-fluorene]
- 1393816-99-3/Descarbonsildenafil
- 1261997-43-6/2-Amino-5-(3-fluoro-4-hydroxyphenyl)pyridine-4-carboxylic acid
- 1013915-99-5/REP 3123 dihydrochloride
- 1184914-28-0/5-Amino-1-methyl-3-(2-methylcyclopropyl)-1H-pyrazole-4-carbonitrile
- 18668-29-6/DES(1-methylpiperidinium)-17-oxo vecuronium
- 1951441-74-9/N-Methyl-1-(3-(trifluoromethyl)pyridin-2-yl)methanamine hydrochloride
- 1357946-73-6/5-(Trifluoromethyl)isoquinolin-3-amine
- 1373223-10-9/(3-Dimethylamino-phenyl)-acetic acid hydrochloride
- 1432053-73-0/1-(1-Isopropylpiperidin-4-yl)pyrazolidin-4-amine
- 1068967-96-3/5-PyriMidinecarboxaMide, N-(5-fluoro-3-Methyl-1H-indol-1-yl)-4-Methyl-2-(2-pyridinyl)-
- 1337882-23-1/1H-Indazole-1-carboxylic acid, 5-methyl-, 1,1-dimethylethyl ester
- 887594-47-0/2-[13-(3-Butyl-oxiranyl)-tridecyl]-3,6-dihydroxy-5-methyl[1,4]benzoquinone
- 939758-78-8/5,7-Difluoro-1,2,3,4-tetrahydroquinoline